Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis

Journal of Rheumatology

Volumn 31, Issue 11, 2004, Pages 2290-2294

  Wallace, Carol A ^a,d   Ruperto, Nicolino ^b   Giannini, Edward H ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Criteria; Juvenile idiopathic arthritis; Remission

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; RHEUMATOID FACTOR;

ARTHRITIS; ARTICLE; CLINICAL FEATURE; CONSENSUS DEVELOPMENT; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; HEALTH STATUS; HUMAN; IDIOPATHIC DISEASE; JUVENILE RHEUMATOID ARTHRITIS; NORMAL HUMAN; POLYARTHRITIS; PRIORITY JOURNAL; PROBABILITY; QUESTIONNAIRE; RECURRENT DISEASE; REMISSION; SCORING SYSTEM; SYSTEMIC DISEASE;

ARTHRITIS, JUVENILE RHEUMATOID; DELPHI TECHNIQUE; HEALTH STATUS; HUMANS; RECOVERY OF FUNCTION; RHEUMATOLOGY;

EID: 7544222361     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998;25:1991-4.
2. Wallace CA, Levinson JE. Juvenile rheumatoid arthritis: outcome and treatment for the 1990s. Rheum Dis Clin North Am 1991;17:891-905.
3. Ruperto N, Ravelli A, Levinson JE, et al. Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. II. Early predictors of outcome. J Rheumatol 1997;24:952-8.
4. Ruperto N, Levinson JE, Ravelli A, et al. Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status. J Rheumatol 1997;24:945-51.
5. Lomater C, Gerloni V, Gattinara M, Mazzotti J, Cimaz R, Fantini F. Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years. J Rheumatol 2000;27:491-6.
6. Oen K, Malleson PN, Cabrai DA, Rosenberg AM, Petty RE, Cheang M. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol 2002;29:1989-99.
7. Minden K, Niewerth M, Listing J, et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002;46:2392-401.
8. Ravelli A, Martini A. Early predictors of outcome in juvenile idiopathic arthritis. Clin Exp Rheumatol 2003;21:S89-93.
9. Flato B, Lien G, Smerdel A, et al. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years. J Rheumatol 2003;30:386-93.
10. Wallace CA, Sherry DD, Mellins ED, Aiken RP. Predicting remission in juvenile rheumatoid arthritis with methotrexate treatment. J Rheumatol 1993;20:118-22.
11. Lovell DJ, Giannini EH, Reiff A, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000;342:763-9.
12. Murray KJ, Lovell DJ. Advanced therapy for juvenile arthritis. Best Pract Res Clin Rheumatol 2002;16:361-78.
13. Fantini F, Gerloni V, Gattinara M, Cimaz R, Arnoldi C, Lupi E. Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year followup. J Rheumatol 2003;30:579-84.
14. Lovell DJ, Giannini EH, Reiff A, et al. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum 2003;48:218-26.
15. Giannini EH for the PRCSG. Etanercept/methotrexate registry in juvenile rheumatoid arthritis (JRA) [abstract]. Pediatric Online Journal 2003;1:49. www.pedrheumonlinejournal.org/June/127.
16. Balsa A, Carmona L, Gonzalez-Alvaro I, Belmonte MA, Tena X, Sanmarti R. Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis. J Rheumatol 2004;31:40-6.
17. Paulus HE. Defining remission in rheumatoid arthritis: what is it? Does it matter? J Rheumatol 2004;31:1-4.
18. Delbecq AL, Van de Ven AH, Gustafson DH. Group techniques for program planning. A guide to nominal group and delphi processes. Middleton, WI: Green Briar Press; 1986.
19. Felson DT, Anderson JJ, Boers M, et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
20. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
21. Rider LG, Giannini EH, Harris-Love M, et al. Defining clinical improvement in adult and juvenile myositis. J Rheumatol 2003;30:603-17.
22. Ruperto N, Ravelli A, Murray KJ, et al. Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003;42:1452-9.
23. Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308-15.